利用紫外光谱技术开发和验证利托那韦原料药和制剂剂型的创新性稳定性指示方法

IF 0.2
Gurram Sai Venkata Nagendra Abhay Raj, Sumanta Mondal, Subhadip Chakraborty, Moumita Ghosh
{"title":"利用紫外光谱技术开发和验证利托那韦原料药和制剂剂型的创新性稳定性指示方法","authors":"Gurram Sai Venkata Nagendra Abhay Raj, Sumanta Mondal, Subhadip Chakraborty, Moumita Ghosh","doi":"10.22376/ijlpr.2023.13.6.p154-p169","DOIUrl":null,"url":null,"abstract":"Ritonavir is a protease inhibitor used to treat HIV/AIDS. It is seldom employed for its antiviral activity but instead as a booster for other protease inhibitors. Our study's significant objective is to develop a new, simple, accurate, precise, and reproducible UV spectrophotometric approach for investigation by apotheosis to analyze ritonavir. Three alternative simple, accurate, and precise UV spectrophotometric techniques-the, zero-order (method A), first-order (method B), and the area under the curve (method C) spectrophotometric methods have been established for the measurement of ritonavir in bulk and pharmaceutical dosage. The drug was dissolved in ethanol, and then 0.063 M Phosphate buffer solution (pH 7.0), and the observed λmax are 271 nm for the zero-order spectrophotometric method (method A), 258 nm for the first-order spectrophotometric method, 260–281 nm for the area under the curve spectrophotometric method (method C). Under the optimum conditions, linear relationships with good correlation coefficients 0.9994–0.9999 were found between the reading and the corresponding concentration of the drug in the range of 10-50 μg/ml. The proposed methods can detect the analyte in the lower limits of 0.24 to 0.38 μg/ml. The precision of the methods was satisfactory, and the percentage relative standard deviation values did not exceed 2%. The proposed methods were successfully applied to the analysis of ritonavir in its bulk and commercial formulations with good repeatability and reproducibility; the label claim percentages ranged from 99.56 to 99.64 ± (0.34-0.63) % w/v. The research findings of the current approach were shown to be more accurate and trustworthy for ritonavir in pharmaceutical dosage forms and bulk pharmaceuticals compared to those previously reported by the spectrophotometric approaches. The proposed techniques can be used for routine inspections without causing any interference from excipients or other substances because of the quick and repeatable analysis.","PeriodicalId":44665,"journal":{"name":"International Journal of Life Science and Pharma Research","volume":"257 ","pages":"0"},"PeriodicalIF":0.2000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Development and Validation of an Innovative Stability Indicating Method Using UVSpectroscopy Techniques for Ritonavir in Bulk Drug and Pharmaceutical Dosage Forms\",\"authors\":\"Gurram Sai Venkata Nagendra Abhay Raj, Sumanta Mondal, Subhadip Chakraborty, Moumita Ghosh\",\"doi\":\"10.22376/ijlpr.2023.13.6.p154-p169\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Ritonavir is a protease inhibitor used to treat HIV/AIDS. It is seldom employed for its antiviral activity but instead as a booster for other protease inhibitors. Our study's significant objective is to develop a new, simple, accurate, precise, and reproducible UV spectrophotometric approach for investigation by apotheosis to analyze ritonavir. Three alternative simple, accurate, and precise UV spectrophotometric techniques-the, zero-order (method A), first-order (method B), and the area under the curve (method C) spectrophotometric methods have been established for the measurement of ritonavir in bulk and pharmaceutical dosage. The drug was dissolved in ethanol, and then 0.063 M Phosphate buffer solution (pH 7.0), and the observed λmax are 271 nm for the zero-order spectrophotometric method (method A), 258 nm for the first-order spectrophotometric method, 260–281 nm for the area under the curve spectrophotometric method (method C). Under the optimum conditions, linear relationships with good correlation coefficients 0.9994–0.9999 were found between the reading and the corresponding concentration of the drug in the range of 10-50 μg/ml. The proposed methods can detect the analyte in the lower limits of 0.24 to 0.38 μg/ml. The precision of the methods was satisfactory, and the percentage relative standard deviation values did not exceed 2%. The proposed methods were successfully applied to the analysis of ritonavir in its bulk and commercial formulations with good repeatability and reproducibility; the label claim percentages ranged from 99.56 to 99.64 ± (0.34-0.63) % w/v. The research findings of the current approach were shown to be more accurate and trustworthy for ritonavir in pharmaceutical dosage forms and bulk pharmaceuticals compared to those previously reported by the spectrophotometric approaches. The proposed techniques can be used for routine inspections without causing any interference from excipients or other substances because of the quick and repeatable analysis.\",\"PeriodicalId\":44665,\"journal\":{\"name\":\"International Journal of Life Science and Pharma Research\",\"volume\":\"257 \",\"pages\":\"0\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2023-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Life Science and Pharma Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22376/ijlpr.2023.13.6.p154-p169\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Life Science and Pharma Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22376/ijlpr.2023.13.6.p154-p169","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

利托那韦是一种用于治疗艾滋病的蛋白酶抑制剂。它很少因其抗病毒活性而被使用,而是作为其他蛋白酶抑制剂的增强剂。本研究的重要目的是建立一种新的、简单、准确、精确、可重复的紫外分光光度法,用于对利托那韦进行神化分析。建立了三种简便、准确、精密的紫外分光光度法——零阶(方法A)、一阶(方法B)和曲线下面积(方法C)分光光度法,分别用于利托那韦原料药和制剂剂量的测定。将药物溶解于乙醇中,再加入0.063 M磷酸盐缓冲溶液(pH 7.0),零级分光光度法(A法)测得的λmax为271 nm,一阶分光光度法测得的λmax为258 nm,曲线下面积分光光度法(C法)测得的λmax为260 ~ 281 nm。读数与相应药物浓度在10 ~ 50 μg/ml范围内呈良好的线性关系,相关系数为0.9994 ~ 0.9999。该方法的检测下限为0.24 ~ 0.38 μg/ml。方法精密度令人满意,相对标准偏差不超过2%。该方法成功地应用于利托那韦原料药和商业制剂的分析,具有良好的重复性和再现性;标签声明百分比范围为99.56至99.64±(0.34-0.63)% w/v。与以前报道的分光光度法相比,目前方法的研究结果对药物剂型和散装药物中的利托那韦更为准确和可靠。由于分析快速、可重复,所提出的技术可用于常规检查,而不会引起辅料或其他物质的干扰。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Development and Validation of an Innovative Stability Indicating Method Using UVSpectroscopy Techniques for Ritonavir in Bulk Drug and Pharmaceutical Dosage Forms
Ritonavir is a protease inhibitor used to treat HIV/AIDS. It is seldom employed for its antiviral activity but instead as a booster for other protease inhibitors. Our study's significant objective is to develop a new, simple, accurate, precise, and reproducible UV spectrophotometric approach for investigation by apotheosis to analyze ritonavir. Three alternative simple, accurate, and precise UV spectrophotometric techniques-the, zero-order (method A), first-order (method B), and the area under the curve (method C) spectrophotometric methods have been established for the measurement of ritonavir in bulk and pharmaceutical dosage. The drug was dissolved in ethanol, and then 0.063 M Phosphate buffer solution (pH 7.0), and the observed λmax are 271 nm for the zero-order spectrophotometric method (method A), 258 nm for the first-order spectrophotometric method, 260–281 nm for the area under the curve spectrophotometric method (method C). Under the optimum conditions, linear relationships with good correlation coefficients 0.9994–0.9999 were found between the reading and the corresponding concentration of the drug in the range of 10-50 μg/ml. The proposed methods can detect the analyte in the lower limits of 0.24 to 0.38 μg/ml. The precision of the methods was satisfactory, and the percentage relative standard deviation values did not exceed 2%. The proposed methods were successfully applied to the analysis of ritonavir in its bulk and commercial formulations with good repeatability and reproducibility; the label claim percentages ranged from 99.56 to 99.64 ± (0.34-0.63) % w/v. The research findings of the current approach were shown to be more accurate and trustworthy for ritonavir in pharmaceutical dosage forms and bulk pharmaceuticals compared to those previously reported by the spectrophotometric approaches. The proposed techniques can be used for routine inspections without causing any interference from excipients or other substances because of the quick and repeatable analysis.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
50.00%
发文量
525
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信